243 related articles for article (PubMed ID: 3019351)
1. Ionic signal transduction in growth factor action.
De Laat SW; Moolenaar WH; Defize LH; Boonstra J; van der Saag PT
Biochem Soc Symp; 1985; 50():205-20. PubMed ID: 3019351
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor and bombesin differ strikingly in the induction of early responses in Swiss 3T3 cells.
Bierman AJ; Koenderman L; Tool AJ; De Laat SW
J Cell Physiol; 1990 Mar; 142(3):441-8. PubMed ID: 2155909
[TBL] [Abstract][Full Text] [Related]
3. Growth factors, oncogenes and inositol lipids.
Berridge MJ
Cancer Surv; 1986; 5(2):413-30. PubMed ID: 3779662
[TBL] [Abstract][Full Text] [Related]
4. Parallel contractile signal transduction pathways activated by receptors for thrombin and epidermal growth factor-urogastrone in guinea pig gastric smooth muscle: blockade by inhibitors of mitogen-activated protein kinase-kinase and phosphatidyl inositol 3'-kinase.
Zheng XL; Renaux B; Hollenberg MD
J Pharmacol Exp Ther; 1998 Apr; 285(1):325-34. PubMed ID: 9536028
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor stimulates protein kinase C in quiescent 3T3 cells without Ca2+ mobilization or inositol phosphate accumulation.
Nånberg E; Morris C; Higgins T; Vara F; Rozengurt E
J Cell Physiol; 1990 May; 143(2):232-42. PubMed ID: 2159012
[TBL] [Abstract][Full Text] [Related]
6. Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on the growth inhibitory and increased phosphatidylinositol (PI) responses induced by epidermal growth factor (EGF) in A431 cells.
Smith KB; Losonczy I; Sahai A; Pannerselvam M; Fehnel P; Salomon DS
J Cell Physiol; 1983 Oct; 117(1):91-100. PubMed ID: 6311852
[TBL] [Abstract][Full Text] [Related]
7. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the epidermal growth factor receptor by mitogenic ligands: effects of bombesin and role of protein kinase C.
Zachary I; Rozengurt E
Cancer Surv; 1985; 4(4):729-65. PubMed ID: 3916643
[TBL] [Abstract][Full Text] [Related]
9. Regulation of inositol phospholipid and inositol phosphate metabolism in chemoattractant-activated human polymorphonuclear leukocytes.
Dillon SB; Murray JJ; Uhing RJ; Snyderman R
J Cell Biochem; 1987 Dec; 35(4):345-59. PubMed ID: 3126197
[TBL] [Abstract][Full Text] [Related]
10. Anti-epidermal growth factor receptor monoclonal antibodies affecting signal transduction.
Reins HA; Steinhilber G; Freiberg B; Anderer FA
J Cell Biochem; 1993 Feb; 51(2):236-48. PubMed ID: 8382707
[TBL] [Abstract][Full Text] [Related]
11. Effects of phorbol ester on mitogen and orthovanadate stimulated responses of cultured human fibroblasts.
Jamieson GA; Etscheid BG; Muldoon LL; Villereal ML
J Cell Physiol; 1988 Feb; 134(2):220-8. PubMed ID: 3346337
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated signalling pathways acting through hydrolysis of membrane phospholipids in cardiomyocytes.
Lamers JM; De Jonge HW; Panagia V; Van Heugten HA
Cardioscience; 1993 Sep; 4(3):121-31. PubMed ID: 8400019
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
Masui H; Moroyama T; Mendelsohn J
Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane signalling via the T11-dependent pathway of human T cell activation. Evidence for the involvement of 1,2-diacylglycerol and inositol phosphates.
Pantaleo G; Olive D; Poggi A; Kozumbo WJ; Moretta L; Moretta A
Eur J Immunol; 1987 Jan; 17(1):55-60. PubMed ID: 2434339
[TBL] [Abstract][Full Text] [Related]
15. Activation of an EGFR/neu chimeric receptor: early intracellular signals and cell proliferation responses.
Pandiella A; Lehvaslaiho H; Magni M; Alitalo K; Meldolesi J
Oncogene; 1989 Nov; 4(11):1299-305. PubMed ID: 2573029
[TBL] [Abstract][Full Text] [Related]
16. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic action of tumor necrosis factor in human fibroblasts: interaction with epidermal growth factor and platelet-derived growth factor.
Palombella VJ; Mendelsohn J; Vilcek J
J Cell Physiol; 1988 Apr; 135(1):23-31. PubMed ID: 3259236
[TBL] [Abstract][Full Text] [Related]
18. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
19. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the epidermal growth factor-receptor kinase.
Schlessinger J
Biochem Soc Symp; 1990; 56():13-9. PubMed ID: 2256959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
